Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARS-CoV-2 Seroprevalence in French Prisons
NCT04516512Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2021
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Determination of the immunological parameters (Immunoglobins G) of the SARS-CoV-2 infection at 7 days. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT04516512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516512.